About LensAR
LensAR is a company based in Orlando (United States) founded in 2004 was acquired by Alcon in March 2025. LensAR has raised $99.01 million across 14 funding rounds from investors including Alcon, Oxford Finance and ALPHAEON. The company has 140 employees as of December 31, 2024. LensAR offers products and services including ALLY Robotic Cataract Laser System and LENSAR Laser System. LensAR operates in a competitive market with competitors including eCential Robotics, Biomodex, SentiAR, Enhatch and inHEART, among others.
- Headquarter Orlando, United States
- Employees 140 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lensar, Inc.
-
Annual Revenue
$53.49 M (USD)26.87as on Dec 31, 2024
-
Net Profit
-$31.4 M (USD)-118.34as on Dec 31, 2024
-
EBITDA
-$3 M (USD)65.52as on Dec 31, 2024
-
Total Equity Funding
$99.01 M (USD)
in 14 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
May 25, 2023
-
Investors
Alcon
& 5 more
-
Employee Count
140
as on Dec 31, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of LensAR
LensAR is a publicly listed company on the NASDAQ with ticker symbol LNSR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of LensAR
LensAR offers a comprehensive portfolio of products and services, including ALLY Robotic Cataract Laser System and LENSAR Laser System.
Robotic system for precise cataract surgery and better patient recovery.
Platform for advanced cataract treatment and surgical guidance.
People of LensAR
Unlock access to complete
Unlock access to complete
Funding Insights of LensAR
LensAR has successfully raised a total of $99.01M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LensAR
LensAR has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Oxford Finance and ALPHAEON.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Locked | Locked | Locked | |
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked |
Investor details for LensAR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LensAR
Investment portfolio details for LensAR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LensAR
Detailed financials for LensAR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lensar Comparisons
Peer comparison for LensAR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LensAR
LensAR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eCential Robotics, Biomodex, SentiAR, Enhatch and inHEART, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
3D printed surgical simulators for medical education and patient-specific preoperative planning
|
|
| Locked | Locked | Locked |
A 3D visualization platform is offered for interventional cardiac procedures.
|
|
| Locked | Locked | Locked |
Provider of mobile enterprise apps for Salesforce
|
|
| Locked | Locked | Locked |
AI-based 3D cardiac models are developed for therapeutic planning.
|
|
| Locked | Locked | Locked |
A platform and headset for 3D ophthalmic visualization are developed.
|
Detailed competitors of LensAR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lensar
Complete news archive for LensAR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LensAR
LensAR was founded in 2004 and raised its 1st funding round 5 years after it was founded.
LensAR is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
LensAR is a funded company, having raised a total of $99.01M across 14 funding rounds to date.
As of Dec 31, 2024, the latest employee count at LensAR is 140.
Annual revenue of LensAR is $53.49M as on Dec 31, 2024.
LensAR was founded in 2004 and is based in Orlando, United States. Operations focus on the development and commercialization of laser systems and advanced 3D imaging for refractive cataract procedures within the medical technology sector. The LensAR Laser System has received FDA clearance for anterior capsulotomy and lens fragmentation tasks. Activities center on enhancing surgical precision through integrated technologies.
LensAR's top competitors include eCential Robotics, SurgAR and Beyeonics Surgical.
LensAR offers ALLY Robotic Cataract Laser System and LENSAR Laser System.
Yes, LensAR is publicly traded on NASDAQ under the ticker symbol LNSR.
LensAR has 6 investors. Key investors include Alcon, Oxford Finance, ALPHAEON, PDL BioPharma, and Aisling Capital.
The ticker symbol of LensAR is LNSR on NASDAQ.